The idea of typing a message or moving a cursor with nothing but your thoughts once belonged to science fiction. For a handful of patients today, it’s a clinical reality. This article walks through what brain-computer interfaces can do right now, where the technology is headed, and the ethical questions it raises — from Neuralink’s first human implant to the quiet progress of non-invasive headsets.

4 related posts

First BCI prototype year: 1973 (Jacques Vidal) ·
First human Neuralink implant: January 2024 ·
BCI clinical trials count (2012): over 100 (from PMC review)

Quick snapshot

1Confirmed facts
2What’s unclear
  • Long-term safety and reliability of invasive BCIs over decades (no long-term data yet) (Non-Invasive BCI Review, PMC)
  • Whether BCIs can fully restore natural movement or speech (Non-Invasive BCI Review, PMC)
  • Regulatory timeline for consumer-grade BCIs (Non-Invasive BCI Review, PMC)
3Timeline signal
  • 1973: Jacques Vidal coins BCI term at UCLA (Liv Hospital)
  • 2024: First Neuralink human implant (Liv Hospital)
  • 2025: Multiple companies in clinical trials (Liv Hospital)
4What’s next

Five facts to ground your understanding of BCI technology.

Below is a reference table of core BCI specs.

Property Details
Definition A system that translates brain signals into commands for external devices
First BCI 1973 by Jacques Vidal at UCLA
First human implant (Neuralink) January 2024 (patient Noland Arbaugh)
Number of BCI clinical trials (2012) Over 100
Primary types Invasive (surgery required) and non-invasive (wearable EEG)

The implication: these five specs reveal a field that moved from academic concept to human trials in just over five decades — a fast timeline for any medical technology.

What does a brain computer interface do?

How does a BCI work?

  • BCI acquires brain signals using EEG, ECoG, or intracortical electrodes (Non-Invasive BCI Review, PMC)
  • Signals are processed to control external devices such as cursors, prosthetic limbs, and communication aids (Ambula EMR: Neurotechnology overview)
The trade-off

Non-invasive EEG headsets are safe and affordable, but their signal resolution is far lower than that of surgically implanted electrodes. The field’s central challenge is bandwidth vs. risk — a balance that defines every clinical decision.

The implication: even the most advanced BCI today is a one-way street — reading intent, not thought. The real breakthrough will be bidirectional communication, which remains experimental.

What is a real world example of BCI?

Medical examples: restoring movement after paralysis

  • The BrainGate system has enabled patients to control robotic arms (Ambula EMR)
  • Neuralink’s first human patient, Noland Arbaugh, used his implant to play chess and browse the internet (Liv Hospital report)

Consumer examples: gaming headsets

  • Non-invasive devices like Emotiv EPOC+ allow users to control games and apps via EEG (Emotiv BCI Guide)

The pattern: these aren’t lab curiosities anymore. Some BCIs have FDA clearance or CE marking, and patients are integrating them into daily life.

How close are we to the brain computer interface?

Current status of research and clinical trials

  • Clinical trials for medical BCIs are ongoing, with over 100 trials reported as of 2012 (PMC review)
  • Neuralink received FDA approval for human trials in 2023, according to coverage from Liv Hospital

Neuralink’s progress and timeline

  • First human implant in January 2024 (patient Noland Arbaugh) (Liv Hospital)

Regulatory hurdles

  • Still challenges in signal resolution, safety, and long-term reliability (Non-Invasive BCI Review, PMC)

The catch: while non-invasive BCIs are safe and available now, their signal quality is far below that of invasive implants. The trade-off between risk and bandwidth defines the field’s pace.

What are the negatives of BCI?

Surgical risks of invasive BCIs

  • Invasive implantation carries risks of infection, bleeding, and tissue damage (Liv Hospital report)

Privacy and data security concerns

  • Unauthorized access to neural data could enable surveillance or manipulation (Ambula EMR)

Ethical issues: brain hacking, inequality

  • Cost and accessibility may widen the gap between those who can afford BCIs and those who cannot (ISO/IEC TR 27599:2025)
The paradox

The very feature that makes BCIs powerful — direct access to neural data — also makes them a target. Without strong regulation, the risks could outweigh the benefits for the most vulnerable patients.

The trade-off: each step toward higher bandwidth brings higher stakes. Patients gain independence, but at the cost of long-term uncertainty.

Does Elon Musk own Neuralink?

What is Elon Musk’s brain chip called?

  • Neuralink’s brain chip is called The Link (Liv Hospital BCI Overview)
  • Elon Musk co-founded Neuralink in 2016 and is the majority owner (Liv Hospital report)

What happened to the guy who got a Neuralink?

  • First human patient Noland Arbaugh received the implant in January 2024 and reportedly can control a computer with his thoughts (Liv Hospital report)

The significance: Neuralink’s high profile has accelerated public interest and investment, but it also sets expectations that may be years ahead of what the technology can deliver.

Six systems, one pattern: invasive implants offer higher bandwidth but higher risk, while non-invasive headsets trade performance for safety.

Here is how the leading BCI platforms compare across approach, regulatory status, and application.

Company Approach Regulatory status Key application
Neuralink Invasive (intracortical) FDA human trials (2023) Computer control for paralysis
Synchron Invasive (endovascular) FDA breakthrough device Messaging and internet browsing
Blackrock Neurotech Invasive (intracortical) FDA investigational device Prosthetic limb control
Paradromics Invasive (intracortical) Preclinical / early trials High-data-rate communication
Precision Neuroscience Invasive (surface array) FDA investigational device Brain mapping and control
Emotiv (non-invasive) Non-invasive (EEG headset) CE-marked, consumer Gaming, wellness, research

The pattern: every invasive player targets medical restoration, while the sole non-invasive player addresses consumer wellness — a clear market split.

Timeline of brain-computer interface development

  • — Jacques Vidal coins the term “brain-computer interface” and demonstrates first prototype at UCLA
  • — First human invasive BCI implant (BrainGate) allows patient to control cursor
  • — BrainGate clinical trial begins at Brown University
  • — Elon Musk co-founds Neuralink
  • — Neuralink demonstrates pig with implanted device; FDA Breakthrough Device designation
  • — FDA approves Neuralink human trial; company begins recruiting
  • — Noland Arbaugh receives first Neuralink implant; controls computer with thought alone
  • — Ongoing clinical trials for Neuralink and other BCI systems; continued research on non-invasive BCIs

What this means: from Vidal’s prototype to a patient playing chess with his mind took 51 years. The next decade may compress that progress further.

What we know — and what remains unclear

Confirmed facts

  • BCI can restore control of external devices for paralyzed patients (PMC review)
  • Neuralink implanted its first device in a human in 2024 (Liv Hospital report)
  • Electroencephalography (EEG) can safely measure brain activity for basic control (Emotiv Guide)

What’s unclear

  • Long-term safety and reliability of invasive BCIs over decades
  • Whether BCIs can fully restore natural movement or speech (Non-Invasive BCI Review, PMC)
  • Regulatory timeline for consumer-grade BCIs (non-medical)
  • Potential for brain-computer interfaces to enhance cognition

Voices from the field

“The goal is to give people with paralysis the ability to control computers and robotic limbs with their thoughts.”

— Lead researcher at Harvard’s BCI lab (Non-Invasive BCI Review)

“I was able to play chess and browse the internet just by thinking about it.”

— Noland Arbaugh, Neuralink’s first patient (Liv Hospital report)

The risk of neural data being stolen or used without consent is not theoretical — it’s a present concern for anyone with an implant.

— Neuroethicist cited in ISO/IEC TR 27599:2025 (ISO standards)

The next few years will determine whether BCIs become a mainstream medical tool or remain a niche for early adopters. For patients with paralysis, the choice is clear: embrace the potential of BCIs to regain independence, or wait for more affordable non-invasive alternatives.

The significance: for paralyzed patients, the decision is less about technology readiness and more about whether the available systems address their actual daily needs.

Don't miss these

Frequently asked questions

Can BCI read thoughts?

No. Current BCIs detect electrical signals related to intent, not abstract thoughts. They require training and decode specific commands like “move cursor left.” (PMC review)

Is BCI safe?

Non-invasive BCIs (EEG headsets) are generally safe. Invasive BCIs carry surgical risks such as infection and bleeding. Long-term safety data is still being collected. (Liv Hospital report)

What is the difference between BCI and BMI?

BCI (brain-computer interface) and BMI (brain-machine interface) are often used interchangeably. Some reserve BMI for systems that control robotic limbs directly. Both refer to direct neural control of external devices.

How much does a BCI cost?

Consumer EEG headsets range from $100–$1,000. Invasive BCI systems are not yet commercially available; costs are covered by clinical trials. Estimates for commercial implants run into tens of thousands of dollars.

Are there non-invasive BCIs?

Yes. Devices like Emotiv EPOC+ and NeuroSky use EEG to measure brain activity. They are used for gaming, wellness, and research, but have lower signal resolution than invasive implants. (Emotiv BCI Guide)

What is the future of BCI?

Expect more clinical trials, improved signal processing, and potential consumer applications. ISO technical reports are laying groundwork for standards (ISO/IEC TR 27599:2025).

Can BCI restore vision or hearing?

Retinal implants and cochlear implants are early forms of BCIs that restore limited vision and hearing. Fully functional “bionic eyes” or “neuroprosthetic ears” remain experimental.

Related reading